High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease

American Journal of Medicine

Volumn 125, Issue 7, 2012, Pages

  Papay, Pavol ^a   Hackner, Klaus ^a   Vogelsang, Harald ^a   Novacek, Gottfried ^a   Primas, Christian ^a   Reinisch, Walter ^a   Eser, Alexander ^a   Mikulits, Andrea ^a   Mayr, Wolfgang R ^a   Körmöczi, Günther F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alloantibody; Inflammatory bowel disease; Red blood cell; Transfusion

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN A; ERYTHROCYTE ANTIBODY; IMMUNOMODULATING AGENT; MERCAPTOPURINE; RHESUS ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSCESS DRAINAGE; ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; AGED; ALLOIMMUNIZATION; AMPUTATION; ANTIBODY DETECTION; AORTA ANEURYSM; AORTA RUPTURE; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD TRANSFUSION REACTION; BREAST CARCINOMA; CHRONIC KIDNEY DISEASE; CHRONIC LYMPHATIC LEUKEMIA; COLON RESECTION; CONCUSSION; CONTROLLED STUDY; CONTUSION; CORONARY ARTERY BYPASS GRAFT; CROHN DISEASE; ENDOPROSTHESIS; ENTERITIS; ERYTHROCYTE TRANSFUSION; ESOPHAGUS CARCINOMA; FEMALE; FEMUR FRACTURE; FEMUR NECK FRACTURE; FIBROSARCOMA; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM SEPTUM DEFECT; HEART TRANSPLANTATION; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; IMMUNOMODULATION; INFLAMMATION; KIDNEY TRANSPLANTATION; LARYNX CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LUNG CARCINOMA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITRAL VALVE REPLACEMENT; MOUTH CARCINOMA; MULTIPLE MYELOMA; MULTIPLE TRAUMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PANCREAS CARCINOMA; PREGNANCY; PRIORITY JOURNAL; RECTUM CARCINOMA; RISK ASSESSMENT; SPINE SURGERY; SPLENECTOMY; TRANSFUSION INDUCED ALLOIMMUNIZATION; ULCERATIVE COLITIS; UROTHELIUM; UTERINE CERVIX CARCINOMA;

ADOLESCENT; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CHILD; ERYTHROCYTES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84862664753     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.11.028     Document Type: Article

References (37)

1. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13(12):1545-1553.
2. Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1299-1307.
3. Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(3):513-519.
4. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190-1197.
5. Garcia-Erce JA, Gomollon F, Munoz M. Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases. World J Gastroenterol. 2009;15(37):4686-4694.
6. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21(1):58-71.
7. Nordvall M, Dziegiel M, Hegaard HK, et al. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion. 2009;49(10):2070-2075.
8. Center for Biologics Evaluation and Research, Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2010. Rockville (MD), 2011. Available at: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ ReportaProblem/TransfusionDonationFatalities/ucm254802.htm. Accessed August 8, 2011.
9. Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine, 11th ed. Oxford, UK: Blackwell Publishing; 2005.
10. Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion. 2008;48(10):2069-2076.
11. Heddle NM, Soutar RL, O'Hoski PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol. 1995;91(4):1000-1005.
12. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion. 2003;43(7):945-952.
13. Mintz PD, ed. Transfusion Therapy: Clinical Principles and Practice, 3rd ed. Bethesda, MD: AABB Press; 2011.
14. Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion. 2007;47(11):2066-2071.
15. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion. 1990;30(6): 532-535.
16. Boctor FN, Ali NM, Mohandas K, Uehlinger J. Absence of D-alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion. 2003;43(2):173-176.
17. Yuan S, Davis R, Lu Q, et al. Low risk of alloimmunization to the D antigen in D- orthotopic liver transplant recipients receiving D+ RBCs perioperatively. Transfusion. 2008;48(12):2653-2655.
18. Cummins D, Contreras M, Amin S, et al. Red cell alloantibody development associated with heart and lung transplantation. Transplantation. 1995;59(10):1432-1435.
19. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006;46(9):1526-1536.
20. Hendrickson JE, Chadwick TE, Roback JD, et al. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007;110(7):2736-2743.
21. Yazer MH, Triulzi DJ, Shaz B, et al. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Transfusion. 2009;49:1070-1075.
22. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4(10):e296.
23. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis. 2010; 4(1):7-27.
24. Körmöczi GF, Dauber EM, Haas OA, et al. Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting. Blood. 2007;110(6):2148-2157.
25. Körmöczi GF, Legler TJ, Daniels GL, et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion. 2004;44:575-580.
26. Tyler LN, Harville TO, Blackall DP. Multiple alloantibodies after transfusion in an infant treated with infliximab. N Engl J Med. 2007; 357(20):2092-2093.
27. Kamper-Jorgensen M, Edgren G, Rostgaard K, et al. Blood transfusion exposure in Denmark and Sweden. Transfusion. 2009;49(5): 888-894.
28. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108(3):759-769.
29. Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion. 2009;49(3):505-512.
30. Issitt PD, Anstee DJ. Applied Blood Group Serology, 4th ed. Durham, NC: Montgomery Scientific Publications; 1998.
31. Schonewille H, van de Watering LM, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006;46(2):250-256.
32. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book, 2nd ed. London: Elsevier; 2004.
33. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010;116(11):1831-1838.
34. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-2031.
35. Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion. 2006;46(4):630-635.
36. Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion. 2009;49(3):453-457.
37. Mittermaier C, Kurz M, Rosskopf K, et al. Autologous blood donation for surgery in inflammatory bowel disease - a report of six cases. Z Gastroenterol. 1999;37(12):1169-1173.